Minister also announces funding for opioid-related projects focusing on peer training, professional education, drug checking and surveillance across Canada
OTTAWA, June 19, 2018 /CNW/ - The opioid crisis continues to devastate Canadians from coast to coast to coast. Today, the Public Health Agency of Canada, on behalf of the federal,
Today, the Honourable Ginette Petitpas Taylor, Minister of Health, announced a series of measures to address industry's opioid marketing practices. This includes announcing the Government's intention to severely restrict most forms of prescription opioid marketing.
While prescription opioids can help Canadians who need them to manage pain, industry marketing can unduly influence health professionals, leading to over-prescription of opioids and further contributing to Canada's opioid crisis.
With today's posting of a formal Notice of Intent, Health Canada launched consultations to seek views on restricting most forms of marketing and advertising of prescription opioids, with the possibility of carefully tailored exemptions to allow for the continued sharing of helpful educational and scientific information. These consultations will be open until July 18, 2018. Until new regulations are in place, Minister Petitpas Taylor is also calling on opioid manufacturers and distributors to immediately cease marketing activities associated with opioids in Canada, on a voluntary basis.
The Minister also announced the creation of a dedicated marketing compliance and enforcement team within Health Canada backed by $5 million in operational resources over five years. This team will proactively monitor opioid marketing to enforce the existing rules around improper advertising, and to take action where necessary, including recommending criminal charges where appropriate. The Government is also exploring the development of new enforcement tools, including administrative fines that could be levied rapidly in the case of less serious violations.
In addition, Minister Petitpas Taylor announced a total of $8.9 million in federal investments from:
"High rates of opioid prescriptions are a contributing factor to Canada's opioid crisis. As Minister, I am calling on industry to act now and stop their marketing activities associated with these products in Canada. I have asked my Department to assess evidence of the benefits and harms of past and current opioid marketing practices. This evidence will inform our plans to severely restrict most forms of opioid marketing through regulation. These measures, along with new funding announced today, will help us to better protect Canadians and to support those dealing with problematic substance use."
The Honourable Ginette Petitpas TaylorMinister of Health
"I am deeply concerned by the opioid crisis in Canada. In 2017, we saw an increase of 34% of apparent opioid-related deaths across Canada when compared to 2016. This is unlike any other public health crisis we have experienced in recent years. It is crucial to deal with both the immediate crisis and the root causes that lead people to problematic substance use, so that solutions will save lives and reverse the trend on this national health crisis."
Dr. Theresa TamChief Public Health Officer of Canada
SOURCE Health Canada
Subscribe to our Free Newsletters!
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...
Blount's disease is a developmental disorder in which the shinbone is affected, resulting in ...View All